CSBR 241220 5.00P (CSBR241220P5000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

CSBR241220P5000

Watchlist

1.20
0.000.00%

15min DelayClose Nov 29 13:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Champions Oncology (NASDAQ:CSBR) Shareholders Have Endured a 61% Loss From Investing in the Stock Three Years Ago
Yahoo FinanceNov 4 05:52 ET
Champions Oncology Announces Agreement With Weill Cornell Medicine
AccesswireOct 16 10:55 ET
Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ...
Yahoo FinanceOct 9 15:05 ET
Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
InvestingOct 9 13:00 ET
Champions Oncology Announces Sudden Loss of President
TipRanksOct 3 11:27 ET
Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business
Yahoo FinanceSep 24 15:48 ET

Comments

jimmy the trader

Sep 11 16:09

Very nice 👍 late entry but still made good

$Champions Oncology (CSBR.US)$

Jaguar8

Sep 11 15:54

NEWS ER

$Champions Oncology (CSBR.US)$
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
Positive
▪️Revenue increased 12% year-over-year to $14.1 million
▪️Margin improved to 50% from 38.8% in the previous year
▪️Achieved adjusted EBITDA of $2.0 million, compared to a loss of $1.7 million last year
▪️Reported net income of $1.3 million
▪️Total costs and operating expenses decreased by $2.4 million or 15.8%
▪️Cost of oncology services decreased by 8.0%
▪️...

Trytosaveabit

Sep 11 15:15

$Champions Oncology (CSBR.US)$ First Quarter Highlights:
Total revenue increased 12% to $14.1 million
Margin improved to 50%
Adjusted EBITDA of $2.0 million
Net income of $1.3 million
EPS 0.01 a 94%+ increase

MARKET-TEST-DUMMY

Aug 29 20:22

Looking like

$Champions Oncology (CSBR.US)$ is on the downward trend for a bit

Jaguar8

Jul 18 15:34

NEWS

$Champions Oncology (CSBR.US)$
Champions Oncology Reports Quarterly Revenue of $14.0 Million
Champions Oncology (Nasdaq: CSBR) reported its financial results for Q4 and fiscal year 2024.
Q4 revenue increased 7% to $14 million, with an adjusted EBITDA income of $884,000.
However, annual revenue decreased 7% to $50.2 million, with a fiscal year 2024 adjusted EBITDA loss of $3.9 million.
The company faced challenges due to the biotech sector's funding environment and pharmaceutical spending p...